Lung Cancer / / edited by Henry S. Park.

Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, rad...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London, England : : IntechOpen,, 2021.
Year of Publication:2021
Language:English
Physical Description:1 online resource (224 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01762nam a2200289 i 4500
001 993603194704498
005 20230628090930.0
006 m o d
007 cr |||||||||||
008 230628s2021 enk o 000 0 eng d
035 |a (CKB)5400000000043272 
035 |a (NjHacI)995400000000043272 
035 |a (EXLCZ)995400000000043272 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
050 4 |a RC280.L8  |b .L864 2021 
082 0 4 |a 616.99424  |2 23 
245 0 0 |a Lung Cancer /  |c edited by Henry S. Park. 
246 |a Lung Cancer  
264 1 |a London, England :  |b IntechOpen,  |c 2021. 
300 |a 1 online resource (224 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on publisher supplied metadata and other sources. 
520 |a Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. 
650 0 |a Lungs  |x Cancer. 
650 0 |a Oncology. 
776 |z 1-78985-638-8 
700 1 |a Park, Henry S.,  |e editor. 
906 |a BOOK 
ADM |b 2023-07-08 12:12:17 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351672490004498&Force_direct=true  |Z 5351672490004498  |b Available  |8 5351672490004498